In October 2022, Smartz won the Kerrin Rennie Award for Excellence in Medical Technology – Improving Quality of Life. The award was established to recognise and profile the innovative and extraordinary contribution of medical technology in improving health outcomes of Australian patients.
Smartz monitors patient wellness including 2 significant issues affecting the elderly in residential aged care facilities; incontinence and pressure injuries.
Smartz also helps efficiency of staff time by reducing unnecessary diaper checks whilst also significantly reducing the invasive manual practices currently used to check when diapers need changing.
There was also a potential reduction in the number of diaper changes by changing the diaper only when really needed thus saving time, and improving toileting routines. These benefits may result in lower overall cost, fewer hospital admissions for UTIs, less waste, and more significantly, better individualised care.
Clinical study results have shown that the time residents are left in wet diapers significantly reduces when carers are alerted when the diaper has reached capacity. This reduces the risk of incontinence associated dermatitis (IAD) and UTIs.
Neina Fahey from the Medical Technology Association of Australia (MTAA) spoke with Peta Jurd, Smartz AG Commercial Director about winning the award.
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
-
Impact of genetic pathologist role across medicine
Dr Marina Berbic is a genetic pathologist and the Deputy Director of Genetics at Douglass Hanly Moir Pathology – a laboratory based in Sydney and part of Sonic Healthcare. The genetics department at Douglass Hanly Moir offers a wider array of genetic tests across many domains, and the medical leadership model ensures the highest possible standard of care and commitment to patient safety.
-
Budget22 A mixed dose of health outcomes
Australian Health Journal met with a number of industry heads after the budget on their journeys so far in lobbying for change, their achievements, some of the disappointments and their thoughts on the road ahead, with an election round the corner.
